These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10548951)

  • 21. Terbinafine-induced acute autoimmune hepatitis in the setting of hepatitis B virus infection.
    Paredes AH; Lewis JH
    Ann Pharmacother; 2007 May; 41(5):880-4. PubMed ID: 17426078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intermittent versus continuous terbinafine in the treatment of toenail onychomycosis: a randomized, double-blind comparison.
    Sigurgeirsson B; Elewski BE; Rich PA; Opper C; Cai B; Nyirady J; Bakshi R
    J Dermatolog Treat; 2006; 17(1):38-44. PubMed ID: 16467022
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Curing onychomycosis: understanding the multitude of variables.
    Lagana FJ
    Clin Podiatr Med Surg; 2004 Oct; 21(4):555-64, vi. PubMed ID: 15450896
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Terbinafine-induced persistent agueusia: first reported case].
    Schmutz JL; Barbaud A; Tréchot P
    Ann Dermatol Venereol; 2000 Mar; 127(3):341. PubMed ID: 10804319
    [No Abstract]   [Full Text] [Related]  

  • 25. Onychomycosis: a new emerging infectious disease in childhood population and adolescents. Report on treatment experience with terbinafine and itraconazole in 36 patients.
    Ginter-Hanselmayer G; Weger W; Smolle J
    J Eur Acad Dermatol Venereol; 2008 Apr; 22(4):470-5. PubMed ID: 18194238
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Terbinafine-induced ageusia and hyposmia].
    Villota Hoyos R; González-Ruiz M
    Aten Primaria; 1999 Feb; 23(2):102-3. PubMed ID: 10081177
    [No Abstract]   [Full Text] [Related]  

  • 27. The new oral antifungal agents for onychomycosis of the toenails.
    Gupta AK; Shear NH
    J Eur Acad Dermatol Venereol; 1999 Jul; 13(1):1-13. PubMed ID: 10565624
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Single-blind, randomized, prospective study on terbinafine and itraconazole for treatment of dermatophyte toenail onychomycosis in the elderly.
    Gupta AK; Konnikov N; Lynde CW
    J Am Acad Dermatol; 2001 Mar; 44(3):479-84. PubMed ID: 11209118
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An independent comparison of terbinafine and itraconazole in the treatment of toenail onychomycosis.
    Cohen AD; Medvesovsky E; Shalev R; Biton A; Chetov T; Naimer S; Shai A; Vardy DA
    J Dermatolog Treat; 2003 Dec; 14(4):237-42. PubMed ID: 14660272
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serious adverse events reporting on systemic terbinafine: a Danish register-based study.
    Bangsgaard N; Saunte DM; Folkenberg M; Zachariae C
    Acta Derm Venereol; 2011 May; 91(3):358-9. PubMed ID: 21290086
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinical inquiries. Which oral antifungal is best for toenail onychomycosis?
    Hinojosa JR; Hitchcock K; Rodriguez JE
    J Fam Pract; 2007 Jul; 56(7):581-2. PubMed ID: 17605954
    [No Abstract]   [Full Text] [Related]  

  • 32. Inverse psoriasis induced by terbinafine.
    Pauluzzi P; Boccucci N
    Acta Derm Venereol; 1999 Sep; 79(5):389. PubMed ID: 10494721
    [No Abstract]   [Full Text] [Related]  

  • 33. [Overdose of nortriptyline during treatment with terbinafine (1st reported case)].
    Schmutz JL; Barbaud A; Tréchot P
    Ann Dermatol Venereol; 1999; 126(8-9):647. PubMed ID: 10530361
    [No Abstract]   [Full Text] [Related]  

  • 34. Single-blind, randomized, prospective study of sequential itraconazole and terbinafine pulse compared with terbinafine pulse for the treatment of toenail onychomycosis.
    Gupta AK; Lynde CW; Konnikov N
    J Am Acad Dermatol; 2001 Mar; 44(3):485-91. PubMed ID: 11209119
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spontaneous tolerance to terbinafine-induced lichenoid drug eruption.
    Teraki Y; Shiohara T
    Dermatology; 2004; 208(1):81-2. PubMed ID: 14730245
    [No Abstract]   [Full Text] [Related]  

  • 36. Thrombocytopenia associated with oral terbinafine.
    Grunwald MH
    Int J Dermatol; 1998 Aug; 37(8):634. PubMed ID: 9732018
    [No Abstract]   [Full Text] [Related]  

  • 37. Oral corticosteroids did not prevent AGEP due to terbinafine.
    Bajaj V; Simpson N
    Acta Derm Venereol; 2006; 86(5):448-9. PubMed ID: 16955194
    [No Abstract]   [Full Text] [Related]  

  • 38. Terbinafine in the treatment of onychomycosis: a review of its efficacy in high-risk populations and in patients with nondermatophyte infections.
    Cribier BJ; Bakshi R
    Br J Dermatol; 2004 Mar; 150(3):414-20. PubMed ID: 15030322
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reversible agranulocytosis associated with oral terbinafine in a pediatric patient.
    Aguilar C; Mueller KK
    J Am Acad Dermatol; 2001 Oct; 45(4):632-4. PubMed ID: 11568763
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral terbinafine-induced bullous pemphigoid.
    Aksakal BA; Ozsoy E; Arnavut O; Ali Gürer M
    Ann Pharmacother; 2003 Nov; 37(11):1625-7. PubMed ID: 14565807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.